Related Experiment Video
Updated: Jul 14, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
[Perception of gyneco-obstetric physicians about hormone replacement therapy]
Sebastián Carranza Lira1, Jeniffer Fragoso Dávila
1Unidad Médica de Alta Especialidad del Hospital de Ginecología y Obstetricia Luis Castelazo Ayala, IMSS. scarranzal@mexis.com
Objective:
To identify which is the medical perception of the gynecology-obstetric physicians (Ob-Gyn's) according to hormone therapy (HT) after WHI trial.
Material And Methods:
104 Ob-Gyn were interrogated, and divided into 5 groups according to their position in the hospital. Descriptive statistics was used and the comparisons were done with Student's t test.
Results:
31.7% of the interviewed were in the fifth decade of life and 71% were male. 93.6% referred that HT might not be used in postmenopausal women older 50 years age. Most of them considered that HT decreases osteoporosis and depression. 90.4% considered that HT must be used premature menopause. 91.3% prescribed progestagens in patients with uterus. Oral route was preferred by 50% and the transdermic in 30.8%. 80.8% referred that combined HT did not increase the possibility of endometrial cancer but it did for breast cancer (71.2%). In the same way they considered that improved vaginal lubrication (95.2%), mood (87.5%), hot-flushes (92.3%) and menstrual disturbances (80.8%). 95.2% considered that HT improves quality of life. 62.5% referred that WHI trial modified the way they prescribe HT. 80.8% considered that low dose HT is as good as conventional dose HT.
Conclusions:
This interview permitted to know the opinion in relation to HT, without difference between the interviewed and world tendency.
Related Concept Videos
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Menopause
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation
